212 related articles for article (PubMed ID: 20818416)
1. The orphan G protein-coupled receptor GPR55 promotes cancer cell proliferation via ERK.
Andradas C; Caffarel MM; Pérez-Gómez E; Salazar M; Lorente M; Velasco G; Guzmán M; Sánchez C
Oncogene; 2011 Jan; 30(2):245-52. PubMed ID: 20818416
[TBL] [Abstract][Full Text] [Related]
2. The putative cannabinoid receptor GPR55 promotes cancer cell proliferation.
Hu G; Ren G; Shi Y
Oncogene; 2011 Jan; 30(2):139-41. PubMed ID: 21057532
[TBL] [Abstract][Full Text] [Related]
3. Identification of GPR55 as a lysophosphatidylinositol receptor.
Oka S; Nakajima K; Yamashita A; Kishimoto S; Sugiura T
Biochem Biophys Res Commun; 2007 Nov; 362(4):928-34. PubMed ID: 17765871
[TBL] [Abstract][Full Text] [Related]
4. The orphan receptor GPR55 drives skin carcinogenesis and is upregulated in human squamous cell carcinomas.
Pérez-Gómez E; Andradas C; Flores JM; Quintanilla M; Paramio JM; Guzmán M; Sánchez C
Oncogene; 2013 May; 32(20):2534-42. PubMed ID: 22751111
[TBL] [Abstract][Full Text] [Related]
5. The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation.
Piñeiro R; Maffucci T; Falasca M
Oncogene; 2011 Jan; 30(2):142-52. PubMed ID: 20838378
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of Sprouty2 in non-small cell lung cancer contributes to tumor malignancy via extracellular signal-regulated kinase pathway-dependent and -independent mechanisms.
Sutterlüty H; Mayer CE; Setinek U; Attems J; Ovtcharov S; Mikula M; Mikulits W; Micksche M; Berger W
Mol Cancer Res; 2007 May; 5(5):509-20. PubMed ID: 17510316
[TBL] [Abstract][Full Text] [Related]
7. Lysophosphatidylinositol induces rapid phosphorylation of p38 mitogen-activated protein kinase and activating transcription factor 2 in HEK293 cells expressing GPR55 and IM-9 lymphoblastoid cells.
Oka S; Kimura S; Toshida T; Ota R; Yamashita A; Sugiura T
J Biochem; 2010 May; 147(5):671-8. PubMed ID: 20051382
[TBL] [Abstract][Full Text] [Related]
8. Concurrent activation of β
Wnorowski A; Such J; Paul RK; Wersto RP; Indig FE; Jozwiak K; Bernier M; Wainer IW
Cell Signal; 2017 Aug; 36():176-188. PubMed ID: 28495590
[TBL] [Abstract][Full Text] [Related]
9. Rhein lysinate suppresses the growth of breast cancer cells and potentiates the inhibitory effect of Taxol in athymic mice.
Lin YJ; Zhen YS
Anticancer Drugs; 2009 Jan; 20(1):65-72. PubMed ID: 19343002
[TBL] [Abstract][Full Text] [Related]
10. A G protein-associated ERK pathway is involved in LPS-induced proliferation and a PTK-associated p38 MAPK pathway is involved in LPS-induced differentiation in resting B cells.
Kim J; Yang HY; Jang YS
Mol Immunol; 2006 Mar; 43(8):1232-42. PubMed ID: 16098594
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of the therapeutic efficacy of taxol by the mitogen-activated protein kinase kinase inhibitor CI-1040 in nude mice bearing human heterotransplants.
McDaid HM; Lopez-Barcons L; Grossman A; Lia M; Keller S; Pérez-Soler R; Horwitz SB
Cancer Res; 2005 Apr; 65(7):2854-60. PubMed ID: 15805287
[TBL] [Abstract][Full Text] [Related]
12. Activation of the orphan receptor GPR55 by lysophosphatidylinositol promotes metastasis in triple-negative breast cancer.
Andradas C; Blasco-Benito S; Castillo-Lluva S; Dillenburg-Pilla P; Diez-Alarcia R; Juanes-García A; García-Taboada E; Hernando-Llorente R; Soriano J; Hamann S; Wenners A; Alkatout I; Klapper W; Rocken C; Bauer M; Arnold N; Quintanilla M; Megías D; Vicente-Manzanares M; Urigüen L; Gutkind JS; Guzmán M; Pérez-Gómez E; Sánchez C
Oncotarget; 2016 Jul; 7(30):47565-47575. PubMed ID: 27340777
[TBL] [Abstract][Full Text] [Related]
13. The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation.
Henstridge CM; Balenga NA; Ford LA; Ross RA; Waldhoer M; Irving AJ
FASEB J; 2009 Jan; 23(1):183-93. PubMed ID: 18757503
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors.
Marampon F; Ciccarelli C; Zani BM
Mol Cancer; 2006 Aug; 5():31. PubMed ID: 16899113
[TBL] [Abstract][Full Text] [Related]
15. Off-target cannabinoid effects mediated by GPR55.
Henstridge CM
Pharmacology; 2012; 89(3-4):179-87. PubMed ID: 22433274
[TBL] [Abstract][Full Text] [Related]
16. ATP-sensitive potassium channels control glioma cells proliferation by regulating ERK activity.
Huang L; Li B; Li W; Guo H; Zou F
Carcinogenesis; 2009 May; 30(5):737-44. PubMed ID: 19176641
[TBL] [Abstract][Full Text] [Related]
17. Activation of MAP kinase by muscarinic cholinergic receptors induces cell proliferation and protein synthesis in human breast cancer cells.
Jiménez E; Montiel M
J Cell Physiol; 2005 Aug; 204(2):678-86. PubMed ID: 15744749
[TBL] [Abstract][Full Text] [Related]
18. Green fluorescent protein tagging of extracellular signal-regulated kinase and p38 pathways reveals novel dynamics of pathway activation during primary and metastatic growth.
Aguirre-Ghiso JA; Ossowski L; Rosenbaum SK
Cancer Res; 2004 Oct; 64(20):7336-45. PubMed ID: 15492254
[TBL] [Abstract][Full Text] [Related]
19. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
[TBL] [Abstract][Full Text] [Related]
20. Epinephrine stimulates esophageal squamous-cell carcinoma cell proliferation via beta-adrenoceptor-dependent transactivation of extracellular signal-regulated kinase/cyclooxygenase-2 pathway.
Liu X; Wu WK; Yu L; Sung JJ; Srivastava G; Zhang ST; Cho CH
J Cell Biochem; 2008 Sep; 105(1):53-60. PubMed ID: 18452159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]